PUBLISHER: Allied Market Research | PRODUCT CODE: 1641788
PUBLISHER: Allied Market Research | PRODUCT CODE: 1641788
Endoscope Disinfection Chemicals Market By Product Type (Glutaraldehyde, Peracetic Acid, Others) , By End User (Hospital and Clinics, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Endoscope Disinfection Chemicals Market
The endoscope disinfection chemicals market was valued at $0.8 billion in 2023 and is projected to reach $1.2 Billion by 2033, growing at a CAGR of 4.2% from 2024 to 2033.
An endoscope is a tubular medical device used to visualize the interior of hollow organs during diagnostic and surgical procedures. The disinfection of these devices is a significantly important process as they come in direct contact with the body fluids. The chemicals used to disinfect the medical device are categorized on the basis of their disinfection levels into high-level, intermediate-level, and low-level disinfectants. Examples of commonly used endoscope disinfection chemicals include glutaraldehyde, peracetic acid, iodophors, and quaternary ammonium compounds.
Exponential increase in the number of endoscopies and minimally invasive surgeries has boosted the demand for chemicals that sterilize medical equipment while maintaining their quality and functionality. Therefore, the recurrent use of endoscopes leads to consistent disinfection, which augments the growth of the endoscope disinfection chemicals market. Furthermore, hospitals and other healthcare facilities are a hub for infectious microorganisms, and this acts as a key driver of the market. This is attributed to the fact that adequate disinfection of medical devices, specifically the ones that come in direct contact with patients' bodies, becomes crucial for the prevention of nosocomial infections. In recent times, the development of new formulations that disinfect endoscopes within minutes is a prominent trend in the market. Manufacturers incorporate several high-level disinfectants, which are used with automated processors to sterilize the endoscopes and improve workflow efficiency.
However, concerns regarding the health hazards and environmental impact associated with the long-term usage of these chemicals hamper the development of the market. On the contrary, the combination of chemical disinfection with other forms of sterilization is poised to open new avenues for the endoscope disinfection chemicals market. For instance, according to Matachana-a manufacturer of steam sterilization equipment-blending the benefits of ethylene oxide, hydrogen peroxide plasma, and low-temperature steam & formaldehyde offers deep disinfection of endoscopes.
Segment Review
The endoscope disinfection chemicals market is segmented into product type, end user, and region. On the basis of product type, the market is divided into glutaraldehyde, peracetic acid, and others. As per end user, it is categorized into hospital & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of product type, the glutaraldehyde segment is expected to dominate the market during the forecast period.
As per end user, the hospital & clinics segment is projected to be the highest shareholder from 2024 to 2033.
Region wise, North America is anticipated to be the highest revenue generator by 2033.
Competition Analysis
The leading players operating in the global endoscope disinfection chemicals market include STERIS, Olympus Corporation, Getinge AB, Borer Chemie AG, Micro-Scientific, LLC, Medalkan, Cantel Medical Corp., Ecolab, Fortive Corporation, and SteelcoBelimed AG. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Average Selling Price Analysis / Price Point Analysis
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product Type
- Glutaraldehyde
- Peracetic Acid
- Others
By End User
- Hospital and Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- STERIS
- Olympus Corporation
- Getinge AB
- Borer Chemie AG
- Micro-Scientific, LLC.
- Medalkan
- Cantel Medical Corp.
- Ecolab
- Fortive Corporation
- SteelcoBelimed AG
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY PRODUCT TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product Type
- 4.2. Glutaraldehyde
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Peracetic Acid
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Others
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
CHAPTER 5: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospital And Clinics
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Ambulatory Surgical Centers
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
CHAPTER 6: ENDOSCOPE DISINFECTION CHEMICALS MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Product Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Endoscope Disinfection Chemicals Market
- 6.2.5.1. Market Size and Forecast, By Product Type
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Endoscope Disinfection Chemicals Market
- 6.2.6.1. Market Size and Forecast, By Product Type
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Endoscope Disinfection Chemicals Market
- 6.2.7.1. Market Size and Forecast, By Product Type
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Product Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Endoscope Disinfection Chemicals Market
- 6.3.5.1. Market Size and Forecast, By Product Type
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Endoscope Disinfection Chemicals Market
- 6.3.6.1. Market Size and Forecast, By Product Type
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Endoscope Disinfection Chemicals Market
- 6.3.7.1. Market Size and Forecast, By Product Type
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Endoscope Disinfection Chemicals Market
- 6.3.8.1. Market Size and Forecast, By Product Type
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Endoscope Disinfection Chemicals Market
- 6.3.9.1. Market Size and Forecast, By Product Type
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Endoscope Disinfection Chemicals Market
- 6.3.10.1. Market Size and Forecast, By Product Type
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Product Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Endoscope Disinfection Chemicals Market
- 6.4.5.1. Market Size and Forecast, By Product Type
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Endoscope Disinfection Chemicals Market
- 6.4.6.1. Market Size and Forecast, By Product Type
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. India Endoscope Disinfection Chemicals Market
- 6.4.7.1. Market Size and Forecast, By Product Type
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. Australia Endoscope Disinfection Chemicals Market
- 6.4.8.1. Market Size and Forecast, By Product Type
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Endoscope Disinfection Chemicals Market
- 6.4.9.1. Market Size and Forecast, By Product Type
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Endoscope Disinfection Chemicals Market
- 6.4.10.1. Market Size and Forecast, By Product Type
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Product Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Endoscope Disinfection Chemicals Market
- 6.5.5.1. Market Size and Forecast, By Product Type
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Endoscope Disinfection Chemicals Market
- 6.5.6.1. Market Size and Forecast, By Product Type
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Endoscope Disinfection Chemicals Market
- 6.5.7.1. Market Size and Forecast, By Product Type
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Endoscope Disinfection Chemicals Market
- 6.5.8.1. Market Size and Forecast, By Product Type
- 6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
- 8.1. STERIS
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Olympus Corporation
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Getinge AB
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Borer Chemie AG
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Micro-Scientific, LLC.
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Medalkan
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Cantel Medical Corp.
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. Ecolab
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Fortive Corporation
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. SteelcoBelimed AG
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
